Huali Industries announced that the company's stock prices on November 1, 4, and 5, 2024 dropped by more than 20% cumulatively over three consecutive trading days, leading to abnormal stock trading fluctuations. Following a self-inspection, the company confirmed that current production and operation activities are normal, with no significant changes in daily operations, and there is no undisclosed material information that should be disclosed. The company plans to acquire 51% equity of Suzhou Shangyuan Asia Vets Technology Co., Ltd. for a total consideration of 0.358 billion yuan in cash. This transaction does not constitute a major asset restructuring and has been approved by the relevant board of directors and shareholders' meeting. The company will fulfill its disclosure obligations in a timely manner based on project progress. Currently, there are no other significant matters affecting stock abnormal fluctuations that should be disclosed but remain undisclosed by the company, its controlling shareholder, or ultimate controller.